These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 3036134

  • 21. Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats.
    Yokota N, Bruneau BG, Fernandez BE, de Bold ML, Piazza LA, Eid H, de Bold AJ.
    Am J Hypertens; 1995 Mar; 8(3):301-10. PubMed ID: 7540847
    [Abstract] [Full Text] [Related]

  • 22. Renal atrial natriuretic peptide receptors binding properties and function are resistant to DOCA-salt-induced hypertension in rats.
    Li X, Woodard GE, Brown J, Rosado JA.
    Regul Pept; 2006 Dec 10; 137(3):114-20. PubMed ID: 16904201
    [Abstract] [Full Text] [Related]

  • 23. Increased release of atrial natriuretic polypeptides in rats with DOCA-salt hypertension.
    Sugimoto T, Ishii M, Hirata Y, Matsuoka H, Sugimoto T, Miyata A, Toshimori T, Masuda H, Kangawa K, Matsuo H.
    Life Sci; 1986 Apr 14; 38(15):1351-8. PubMed ID: 2937987
    [Abstract] [Full Text] [Related]

  • 24. Dehydration increases the density of C receptors for ANF on rat glomerular membranes.
    Kollenda MC, Vollmar AM, McEnroe GA, Gerbes AL.
    Am J Physiol; 1990 Apr 14; 258(4 Pt 2):R1084-8. PubMed ID: 2158751
    [Abstract] [Full Text] [Related]

  • 25. Characterization and physiologic regulation of atrial natriuretic factor receptors in rabbit preglomerular renal microvessels.
    Chaudhari A, Nakamura S, Kirschenbaum MA.
    Life Sci; 1991 Apr 14; 48(5):403-8. PubMed ID: 1671521
    [Abstract] [Full Text] [Related]

  • 26. Defective ANF-R2/ANP-C receptor-mediated signalling in hypertension.
    Marcil J, Anand-Srivastava MB.
    Mol Cell Biochem; 1995 Apr 14; 149-150():223-31. PubMed ID: 8569733
    [Abstract] [Full Text] [Related]

  • 27. Binding sites for atrial natriuretic factor (ANF) in kidneys and adrenal glands of spontaneously hypertensive (SHR) rats.
    Swithers SE, Stewart RE, McCarty R.
    Life Sci; 1987 Apr 27; 40(17):1673-81. PubMed ID: 3031407
    [Abstract] [Full Text] [Related]

  • 28. Ganglionic immunoreactive atrial natriuretic factor in rat experimental hypertension.
    Kuchel O, Debinski W, Buu NT, Cantin M, Genest J.
    Hypertension; 1988 Feb 27; 11(2 Pt 2):I47-51. PubMed ID: 2964403
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Glomerular ANF receptor regulation during changes in sodium and water metabolism.
    Gauquelin G, Garcia R, Carrier F, Cantin M, Gutkowska J, Thibault G, Schiffrin EL.
    Am J Physiol; 1988 Jan 27; 254(1 Pt 2):F51-5. PubMed ID: 2827518
    [Abstract] [Full Text] [Related]

  • 32. Computerized approach using autoradiography to quantify atrial natriuretic peptide receptors in the DOCA-salt hypertensive rat kidney.
    Takatori K, Ogura T, Ota Z.
    Regul Pept; 1991 Aug 13; 35(2):115-25. PubMed ID: 1661902
    [Abstract] [Full Text] [Related]

  • 33. Transient downregulation of glomerular atrial natriuretic factor receptors in high output heart failure in the rat.
    Gauquelin G, Bonhomme MC, Garcia R.
    Cardiovasc Res; 1995 Mar 13; 29(3):385-90. PubMed ID: 7781012
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Phasic plasma atrial natriuretic polypeptide changes in DOCA-salt hypertensive rats.
    Sato Y, Ito Y, Ando K, Ogata E, Fujita T.
    Jpn Heart J; 1990 Sep 13; 31(5):703-11. PubMed ID: 2148777
    [Abstract] [Full Text] [Related]

  • 36. Atrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat.
    Ballermann BJ, Bloch KD, Seidman JG, Brenner BM.
    J Clin Invest; 1986 Sep 13; 78(3):840-3. PubMed ID: 3018046
    [Abstract] [Full Text] [Related]

  • 37. Downregulation of glomerular and vascular atrial natriuretic factor receptor subtypes by angiotensin II.
    Gauquelin G, Schiffrin EL, Garcia R.
    J Hypertens; 1991 Dec 13; 9(12):1151-60. PubMed ID: 1663970
    [Abstract] [Full Text] [Related]

  • 38. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P, Vuolteenaho O, Ruskoaho H.
    Endocrinology; 1992 Feb 13; 130(2):755-65. PubMed ID: 1531129
    [Abstract] [Full Text] [Related]

  • 39. DOCA administration and atrial natriuretic factor in dogs with chronic heart failure.
    Villarreal D, Freeman RH, Brands MW.
    Am J Physiol; 1989 Sep 13; 257(3 Pt 2):H739-45. PubMed ID: 2528918
    [Abstract] [Full Text] [Related]

  • 40. Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitor.
    Watkins RW, Vemulapalli S, Chiu PJ, Foster C, Smith EM, Neustadt B, Haslanger M, Sybertz EJ.
    Am J Hypertens; 1993 May 13; 6(5 Pt 1):357-68. PubMed ID: 8512660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.